SCHEMBL6514442

SCHEMBL6514442

NC(=O)c1ccc(Cn2cc(-c3ccc(Cl)cc3Cl)nc2C=Cc2ccc(Br)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.37
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
GPR183 P32249 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
DRD2 P14416 1/20 0.35
LMNA P02545 1/20 0.35
ADRA1D P25100 2/20 0.35
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
HDAC6 Q9UBN7 2/20 0.34
CDC7 O00311 1/20 0.34
CCNE1 P24864 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6514437 1.00 DHODH (0.37) DHODHMAPTPOLBGPR183NPC1
SCHEMBL1676211 0.92 KDM4E (0.44) DHODHMAPTPOLBGPR183NPC1
SCHEMBL1676214 0.92 KDM4E (0.44) DHODHMAPTPOLBGPR183NPC1
SCHEMBL1482273 0.88 DRD2 (0.49) MAPTPOLBDRD2HDAC6
SCHEMBL1482277 0.88 DRD2 (0.49) MAPTPOLBDRD2HDAC6
SCHEMBL1676642 0.88 LMNA (0.41) DHODHMAPTGPR183LMNAHDAC6
SCHEMBL1676640 0.88 LMNA (0.41) DHODHMAPTGPR183LMNAHDAC6
SCHEMBL1482079 0.85 DRD2 (0.38) DHODHMAPTPOLBGPR183DRD2
SCHEMBL1482075 0.85 DRD2 (0.38) DHODHMAPTPOLBGPR183DRD2
SCHEMBL1481483 0.84 KDM4E (0.44) MAPTPOLBNPC1RAB9ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187277-A1 Substituted azole derivatives, compositions, and methods of use TRANSTECH PHARMA, INC. 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187277-A1 Substituted azole derivatives, compositions, and methods of use PTPRO, PTPN5, PTPRE DHODH 902/4885MAPT 3251/4885POLB 4497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.